Computer-driven molecular design, with its ability to generate massive quantities of simulated data, facilitates entry into new frontiers of chemical discovery for...
In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a...
29.01.2020
- Schrödinger, a New York, USA-based computational platform provider, and Germany’s Bayer entered into a 5-year technology alliance to develop a comprehensive de novo design solution...
